Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI

被引:0
|
作者
Su, Min-Ying [1 ]
Baik, Hyun-Man
Yu, Hon J.
Chen, Jeon-hor
Mehta, Rita S.
Nalcioglu, Orhan
机构
[1] Univ Calif Irvine, John Tu & Thomas Yuen Ctr Funct Oncoimaging, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA
关键词
breast cancer; choline; dynamic contrast enhanced MRI; MR spectroscopic imaging; neoadjuvant chemotherapy; and pharmacokinetic parameters;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although an MRI scanner is a single stand-alone modality, different acquisition techniques may be applied to collect structural and functional information, including vascular or angiogenic properties measured by dynamic contrast enhanced MRI (DCE-MRI) and Choline (Cho) metabolism measured by proton MR spectroscopy imaging (MRSI). They may provide complementary information for a better characterization of neoplasm. In this study, we investigated the correlation between Choline measured by MRSI and vascular parameters measured by DCE-MRI in breast cancer. Fourteen patients with histologically proven invasive breast cancer were included. MRSI from a grid of 8 x 8 voxels within a selected slab from each lesion was performed. Each voxel was 1.0 x 1.0 x 1.2 cm(3). Choline signal-to-noise ratio (SNR) was measured from each voxel showing an identifiable Choline peak. Corresponding DCE kinetics was measured from each voxel, and analyzed with a 2-compartmental model to obtain pharmacokinetic parameters K-trans and k(ep). All parameters showed a wide variation within each lesion, and there were no consistent correlations between regional Cho and DCE parameters within the lesion of each individual patient. This finding might be attributed to the heterogeneous nature of breast cancer. The characteristic Cho and DCE-MRI parameters were obtained for each patient by averaging over all Cho-positive voxels. In these 14 patients there was a significant linear correlation between Cho with percent enhancement at 2 min after injection, SE%-2min (r = 0.75, p = 0.002), and pharmacokinetic parameters K-trans (r = 0.74, p = 0.003), and k(ep) (r = 0.76, p = 0.002). The results suggested that overall there is a correlation between Choline metabolism and angiogenesis activity. Since Choline is associated with cell replication and angiogenesis is required to support tumor growth, this might explain the correlation between these two sets of measures among different lesions.
引用
收藏
页码:401 / 410
页数:10
相关论文
共 50 条
  • [41] Enhanced Mass on Contrast-Enhanced Breast MR Imaging: Lesion Characterization Using Combination of Dynamic Contrast-Enhanced and Diffusion-Weighted MR Images
    Yabuuchi, Hidetake
    Matsuo, Yoshio
    Okafuji, Takashi
    Kamitani, Takeshi
    Soeda, Hiroyasu
    Setoguchi, Taro
    Sakai, Shuji
    Hatakenaka, Masamitsu
    Kubo, Makoto
    Sadanaga, Noriaki
    Yamamoto, Hidetaka
    Honda, Hiroshi
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2008, 28 (05) : 1157 - 1165
  • [42] Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters
    Sitter, B
    Lundgren, S
    Bathen, TF
    Halgunset, J
    Fjosne, HE
    Gribbestad, IS
    NMR IN BIOMEDICINE, 2006, 19 (01) : 30 - 40
  • [43] Quantitative dynamic contrast-enhanced MRI parameters effectively predict treatment efficacy of neoadjuvant chemotherapy in breast cancer
    Xu, Ling
    Zhou, Fangfang
    Su, Lianzi
    Wang, Longsheng
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2025, 17 (02): : 1039 - 1048
  • [44] Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging at 7T for Breast Cancer Diagnosis and Characterization
    Ochoa-Albiztegui, R. Elena
    Sevilimedu, Varadan
    Horvat, Joao, V
    Thakur, Sunitha B.
    Helbich, Thomas H.
    Trattnig, Siegfried
    Morris, Elizabeth A.
    Reiner, Jeffrey S.
    Pinker, Katja
    CANCERS, 2020, 12 (12) : 1 - 17
  • [45] Choline by magnetic spectroscopy and dynamic contrast enhancement curve by magnetic resonance imaging in neoadjuvant chemotherapy for invasive breast cancer
    Murata, Yoriko
    Hamada, Norihiko
    Kubota, Kei
    Miyatake, Kana
    Tadokoro, Michiko
    Kataoka, Yuko
    Ue, Hironobu
    Tsuzuki, Kazuhiro
    Kariya, Shinji
    Nishka, Akihito
    Ogawa, Yasuhiro
    MOLECULAR MEDICINE REPORTS, 2009, 2 (01) : 39 - 43
  • [46] Convolutional Neural Networks for Direct Inference of Pharmacokinetic Parameters: Application to Stroke Dynamic Contrast-Enhanced MRI
    Ulas, Cagdas
    Das, Dhritiman
    Thrippleton, Michael J.
    Valdes Hernandez, Maria del C.
    Armitage, Paul A.
    Makin, Stephen D.
    Wardlaw, Joanna M.
    Menze, Bjoern H.
    FRONTIERS IN NEUROLOGY, 2019, 9
  • [47] Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling
    Albert C. Yeh
    Hui Li
    Yitan Zhu
    Jing Zhang
    Galina Khramtsova
    Karen Drukker
    Alexandra Edwards
    Stephanie McGregor
    Toshio Yoshimatsu
    Yonglan Zheng
    Qun Niu
    Hiroyuki Abe
    Jeffrey Mueller
    Suzanne Conzen
    Yuan Ji
    Maryellen L. Giger
    Olufunmilayo I. Olopade
    Cancer Imaging, 19
  • [48] Standardization of Radiological Evaluation of Dynamic Contrast Enhanced MRI: Application in Breast Cancer Diagnosis
    Furman-Haran, E.
    Feinberg, M. Shapiro
    Badikhi, D.
    Eyal, E.
    Zehavi, T.
    Degani, H.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2014, 13 (05) : 445 - 454
  • [49] Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling
    Yeh, Albert C.
    Li, Hui
    Zhu, Yitan
    Zhang, Jing
    Khramtsova, Galina
    Drukker, Karen
    Edwards, Alexandra
    McGregor, Stephanie
    Yoshimatsu, Toshio
    Zheng, Yonglan
    Niu, Qun
    Abe, Hiroyuki
    Mueller, Jeffrey
    Conzen, Suzanne
    Ji, Yuan
    Giger, Maryellen L.
    Olopade, Olufunmilayo I.
    CANCER IMAGING, 2019, 19 (1):
  • [50] The kinetic parameters of dynamic contrast-enhanced MRI with ultrafast imaging in breast cancer patients receiving neoadjuvant chemotherapy: Prediction of pathologic complete response and correlation with histologic microvessel density
    Choi, Sung-Eun
    Park, Ah Young
    Kim, Gwang Il
    Jung, Hae Kyoung
    Ko, Kyung Hee
    Kim, Yunju
    MEDICINE, 2025, 104 (05) : e40239